NIH director Francis S. Collins to step down by end of year
The director of the National Institutes of Health, Dr. Francis S
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The director of the National Institutes of Health, Dr. Francis S. Collins, says he is stepping down by the end of the year, having led the research center for 12 years and become a prominent source of public information during the coronavirus pandemic.
“There comes a time where an institution like NIH really benefits from new vision, new leadership,” Collins, 71, said in an interview with The Washington Post. “This was the right timing.”
A formal announcement was expected Tuesday from NIH. The Post and Politico reported Collins' plans Monday night.
Based in Bethesda, Maryland, and a part of the Department of Health and Human Services, NIH is the nation’s medical research agency and operates more than two dozen institutes and centers. It lays claim to being the largest supporter of biomedical research in the world.
Collins was appointed director in 2009 by President Barack Obama and was asked to remain in that post by Presidents Donald Trump and Joe Biden He is the only presidentially appointed NIH director to serve under multiple administrations.
In the interview with the Post, Collins said he had decided not to stay too long into the Biden administration and was confident that the NIH's role in developing therapeutics, tests and vaccines for the coronavirus had reached “a pretty stable place.”
Collins served as director of NIH's National Human Genome Research Institute from 1993-2008 and led the international Human Genome Project which in 2003 completed a finished sequence of the human DNA instruction book.